Wordwide magazine
Campus Penn Medicine on October 3, 2020. Credit: Max Mester The Federal Drug Administration recently approved a drug being trialled by the Penn Memory Center to reduce the risk of Alzheimer’s disease. The drug, Leqembi, won FDA approval under the accelerated approval pathway on January 6, after the AHEAD trial evaluating its efficacy in volunteers … Read more
In subjects with Alzheimer’s disease, the greatest positive effect was observed when stimulating the area between the fornix (green) and the fundus nucleus of the stria terminalis (blue). Also shown are two structures of the brain—thalamus (pink) and hippocampus (yellow)—as well as the stimulation electrodes. Credit: © Charité | Ana Sophia Rios Researchers at Charité … Read more
summary: Researchers have developed a new family of nanocapsules that are able to carry CRISPR gene-editing tools to different organs of the body before they degrade harmlessly. The capsules were able to enter the brains of mice and successfully edit a gene associated with Alzheimer’s disease. Source: University of Wisconsin-Madison Gene therapies have the potential … Read more
Written by Katie Cobb | January 20, 2023 Through a 23andMe test, Wendy Nelson, PhD, discovered that she carried two copies of the Alzheimer’s disease biomarker ApoE4 – the “Alzheimer’s gene”. It has changed the way she thinks about brain health. When Wendy Nelson, Ph. D., discovered she carried two copies of the Alzheimer’s disease … Read more
According to a new study, just six minutes of high-intensity exercise can extend the life of a healthy brain and delay the onset of neurodegenerative disorders such as Alzheimer’s and Parkinson’s. The research found that a short but intense bout of cycling increases production of a protein essential for brain formation, learning and memory, and … Read more